$11.7MVenture, 10 March 2026
Funds completion of its pivotal US trial and European launch of the CE-marked Anavi System.
- Amount
- $11.7M
- Stage
- Venture
- Announced
- 10 March 2026
- Lead
- Sofinnova Partners
- Other investors
- Bpifrance, Trill Impact, Nexpring Health
- Use of funds
- Funds completion of its pivotal US trial and European launch of the CE-marked Anavi System.
- Checked
- Announced by the company
- Sources
- May Health raises €10M to advance PCOS infertility treatment businesswire.com
May Health raises €10M to advance PCOS infertility treatment pulse2.com